1-4 of 4
Rupert Öllinger
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting Extracellular Vesicle Secretion in Combination with Venetoclax Synergistically Induces Apoptosis in FLT3-ITD+ AML

Judith S. Hecker, Jennifer Rivière, Mark van der Garde, Michèle C. Buck, Rupert Öllinger, Florian Bassermann, Bernd Giebel, Robert A.J. Oostendorp, Roland Rad, Katharina S. Goetze
Journal: Blood
Blood (2022) 140 (Supplement 1): 8711–8712.
https://doi.org/10.1182/blood-2022-169065
Published: 2022
Journal Articles

MondoA drives malignancy in B-ALL through enhanced adaptation to metabolic stress

Alexandra Sipol, Erik Hameister, Busheng Xue, Julia Hofstetter, Maxim Barenboim, Rupert Öllinger, Gaurav Jain, Carolin Prexler, Rebeca Alba Rubio, Michaela C. Baldauf, Davide G. Franchina, Andreas Petry, Juliane Schmäh, Uwe Thiel, Agnes Görlach, Gunnar Cario, Dirk Brenner, Günther H. S. Richter, Thomas G. P. Grünewald, Roland Rad, Elmar Wolf, Jürgen Ruland, Poul H. Sorensen, Stefan E. G. Burdach
Journal: Blood
Blood (2022) 139 (8): 1184–1197.
https://doi.org/10.1182/blood.2020007932
Published: 2022
Includes: Supplemental data
Journal Articles

In Vivo CRISPR-Cas9 Screens in PDX Models Reveals ADAM10 As Novel Therapeutic Target in Acute Leukemia

Ehsan Bahrami, Jan Philipp Schmid, Martin Becker, Anna-Katharina Wirth, Rupert Öllinger, Roland Rad, Binje Vick, Ashok Kumar Jayavelu, Matthias Mann, Tobias Herold, Irmela Jeremias
Journal: Blood
Blood (2021) 138 (Supplement 1): 708.
https://doi.org/10.1182/blood-2021-149658
Published: 2021
Journal Articles

A CRISPR/Cas9 Library Screen in Patients' Leukemia Cells In Vivo

Ehsan Bahrami, PhD, Martin Becker, PhD, Anna-Katharina Wirth, MSc, Jan Phillip Schmid, MSc, Tobias Herold, MD, Rupert Öllinger, PhD, Roland Rad, Irmela Jeremias, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3945.
https://doi.org/10.1182/blood-2019-124288
Published: 2019